title: Reply to I.A. Voutsadakis et al and A. Goyal et al.
authors.affiliation: Cedars-Sinai Medical Center, Los Angeles, CA.
authors.forename: Armando E
authors.initials: AE
authors.lastname: Giuliano
authors.affiliation: Wilshire Oncology Medical Group, Rancho Cucamonga, CA.
authors.forename: Linda D
authors.initials: LD
authors.lastname: Bosserman
authors.affiliation: Baptist Cancer Center, Memphis, TN.
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Edge
authors.affiliation: University of Vermont College of Medicine and Vermont Cancer Center, Burlington, VT.
authors.forename: Donald L
authors.initials: DL
authors.lastname: Weaver
authors.affiliation: Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA.
authors.forename: Gary H
authors.initials: GH
authors.lastname: Lyman
mesh_terms: D001943:Breast Neoplasms / Q000473:pathology*; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D008495:Medical Oncology / Q000592:standards*; D021701:Sentinel Lymph Node Biopsy / Q000379:methods* / Q000592:standards*